Clinical Use of Creatine in Neuromuscular and Neurometabolic Disorders
Author:
Tarnopolsky Mark A.
Publisher
Springer Netherlands
Reference90 articles.
1. Adcock, K.H., Nedelcu, J., Loenneker, T., Martin, E., Wallimann, T., and Wagner, B.P., 2002, Neuroprotection of creatine supplementation in neonatal rats with transient cerebral hypoxia-ischemia. Dev. Neurosci.
24: 382–388. 2. Alexanderson, H., 2005, Exercise: an important component of treatment in the idiopathic inflammatory myopathies. Curr, Rheumatol. Rep.
7: 115–124. 3. Andreassen, O.A., Dedeoglu, A., Ferrante, R.J., Jenkins, B.G., Ferrante, K.L., Thomas, M., Friedlich, A., Browne, S.E., Schilling, G., Borchelt, D.R., Hersch, S.M., Ross, C.A., and Beal, M.F., 2001, Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington’s disease. Neurobiol. Dis.
8: 479–491. 4. Argov, Z., De Stefano, N., and Arnold, D.L., 1996, ADP recovery after a brief ischemic exercise in normal and diseased human muscle – a 31P MRS study. NMR Biomed.
9: 165–172. 5. Arnardottir, S., Alexanderson, H., Lundberg, I.E., and Borg, K., 2003, Sporadic inclusion body myositis: pilot study on the effects of a home exercise program on muscle function, histopathology and inflammatory reaction. J. Rehabil. Med.
35: 31–35.
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|